Mucopolysaccharidosis type ii (mps ii) Clinical Trials
Conditions / Mucopolysaccharidosis type ii (mps ii)
Delta Trials records 3 clinical trials for Mucopolysaccharidosis type ii (mps ii) in its publicly accessible dataset. From the full dataset, 0 actively seeking eligible participants and 2 trials have reached completion. This research is conducted across 9 study locations around the world. An additional 1 trial are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
3
Total Trials
0
Recruiting
2
Completed
1
Other Active
0
Terminated since 2020
9
Study Locations
Browse by location (9 total)
- Oakland, United States 2 trialsAll trials in Oakland, United States
- Buffalo, United States 1 trialAll trials in Buffalo, United States
- Montréal, Canada 1 trialAll trials in Montréal, Canada
- Montréal, Canada 1 trialAll trials in Montréal, Canada
- Montréal, Canada 1 trialAll trials in Montréal, Canada
- Minneapolis, United States 1 trialAll trials in Minneapolis, United States
- Chicago, United States 1 trialAll trials in Chicago, United States
- Pittsburgh, United States 1 trialAll trials in Pittsburgh, United States
- New Brunswick, United States 1 trialAll trials in New Brunswick, United States
- Porto Alegre, Brazil 1 trialAll trials in Porto Alegre, Brazil
- Porto Alegre, Brazil 1 trialAll trials in Porto Alegre, Brazil
- Philadelphia, United States 1 trialAll trials in Philadelphia, United States